Ramipril for the Treatment of Oligospermia: A Double-Blind Randomized Control Trial
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Ramipril (Primary)
- Indications Asthenozoospermia; Male infertility; Oligospermia; Teratospermia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 27 Apr 2017 Status changed from recruiting to discontinued.
- 01 Jul 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.